Brainstorm Cell Therapeutics Shares Are Trading Lower After the Company Announced It Received a Letter From the Nasdaq Indicating That It Did Not Regain Compliance With the Minimum Bid Price Requirement.
Brainstorm Cell Therapeutics Shares Are Trading Lower After the Company Announced It Received a Letter From the Nasdaq Indicating That It Did Not Regain Compliance With the Minimum Bid Price Requirement.
Brainstorm Cell Therapeutics宣布收到纳斯达克的一封信表明其没有恢复遵守最低出价要求后，该公司股价走低。
Brainstorm Cell Therapeutics Shares Are Trading Lower After the Company Announced It Received a Letter From the Nasdaq Indicating That It Did Not Regain Compliance With the Minimum Bid Price Requirement.
Brainstorm Cell Therapeutics宣布收到纳斯达克的一封信表明其没有恢复遵守最低出价要求后，该公司股价走低。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。